InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by LaBrosse Nicole, Chief Financial Officer. Insider active across 1 company, notably Halozyme Therapeutics, INC.. Cumulatively, 3 filings have been logged. Activity tracked since 10 February 2022. The latest transaction was disclosed on 15 February 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
1,255 shares0Common StockSEC:0001179110-22-001393:0
1,255 shares0Common StockSEC:0001179110-22-001393
2,503 shares0Common StockSEC:0001179110-22-001200:0
3 of 3 declarations
About LaBrosse Nicole
Nicole LaBrosse is SVP and Chief Financial Officer at Halozyme Therapeutics, Inc. In this role, she is responsible for the company's financial management, including financial planning and reporting. Her expertise is essential in supporting strategic decisions and ensuring the financial health of the organization.
